Viatris Announces U.S. FDA Tentative Approval of a Paediatric Formulation of Abacavir (ABC)/Dolutegravir (DTG)/Lamivudine (3TC), a Once-daily Treatment for Children Living with HIV

Tentative approval will help enhance access to WHO-recommended paediatric regimen with the goal of improved adherence of HIV treatment for children in low- and middle-income countries
PITTSBURGH and...

Related Keywords

Shanghai ,China ,Bangalore ,Karnataka ,India ,Hyderabad ,Andhra Pradesh ,Rakesh Bamzai ,Instagram ,Twitter ,Youtube ,Clinton Health Access Initiative ,World Health Organization ,Linkedin ,United Nations Programme ,Drug Administration ,Viatris Inc ,Exchange Commission ,Nasdaq ,New Drug Application ,Joint United Nations Programme ,Emergency Plan ,Medicines Patent Pool ,Viiv Healthcare ,Emerging Asia ,Access Markets ,Global Healthcare Gateway ,Safety Information ,Severe Hepatomegaly ,Fetal Toxicity ,Virologic Response Due ,Drug Interactions ,Reconstitution Syndrome ,Formulations Are Not Interchangeable ,Prescribing Information ,Renal Function ,Private Securities Litigation Reform Act ,Fair Disclosure ,Markets ,